Shared changes in gene expression in frontal cortex of four genetically modified mouse models of depression

European Neuropsychopharmacology

Volumn 21, Issue 1, 2011, Pages 3-10

  Hoyle, D ^a   Juhasz, G ^b   Aso, E ^c   Chase, D ^b   del Rio, J ^d   Fabre, V ^e   Hamon, M ^e   Lanfumey, L ^e   Lesch, K P ^f   Maldonado, R ^c   Serra, M A ^c   Sharp, T ^g   Tordera, R ^d   Toro, C ^h   Deakin, J F W ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d UNIVERSITY OF NAVARRA   (Spain)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f UNIVERSITY OF WÜRZBURG   (Germany)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h CRANFIELD UNIVERSITY   (United Kingdom)

Author keywords

Cellular stress; ; Depression; ; Gene expression; ; Remodelling

Indexed keywords

CANNABINOID 1 RECEPTOR; GLUCOCORTICOID RECEPTOR; MESSENGER RNA; VESICULAR GLUTAMATE TRANSPORTER 1;

ANHEDONIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; CELL STRESS; CONTROLLED STUDY; DEPRESSION; DNA MODIFICATION; DOWN REGULATION; FRONTAL CORTEX; GENE EXPRESSION; KNOCKOUT MOUSE; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 78650677710     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2010.09.011     Document Type: Article

References (56)

1. Abou-Saleh M.T., Anderson D.N., Collins J., Hughes K., Cattell R.J., Hamon C.G., et al. The role of pterins in depression and the effects of antidepressive therapy. Biol. Psychiatry 1995, 38:458-463.
2. Allison D.B., Cui X., Page G.P., Sabripour M. Microarray data analysis: from disarray to consolidation and consensus. Nat. Rev. Genet. 2006, 7:55-65.
3. Altar C.A., Vawter M.P., Ginsberg S.D. Target identification for CNS diseases by transcriptional profiling. Neuropsychopharmacology 2009, 34:18-54.
4. Alttoa A., Koiv K., Hinsley T.A., Brass A., Harro J. Differential gene expression in a rat model of depression based on persistent differences in exploratory activity. Eur. Neuropsychopharmacol. 2010, 20:288-300.
5. Aso E., Renoir T., Mengod G., Ledent C., Hamon M., Maldonado R., et al. Lack of CB1 receptor activity impairs serotonergic negative feedback. J. Neurochem. 2009, 109:935-944.
6. Belmaker R.H., Agam G. Major depressive disorder. N. Engl. J. Med. 2008, 358:55-68.
7. Bengel D., Murphy D.L., Andrews A.M., Wichems C.H., Feltner D., Heils A., et al. Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice. Mol. Pharmacol. 1998, 53:649-655.
8. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 1995, 57:289-300.
9. Bergstrom A., Jayatissa M.N., Thykjaer T., Wiborg O. Molecular pathways associated with stress resilience and drug resistance in the chronic mild stress rat model of depression: a gene expression study. J. Mol. Neurosci. 2007, 33:201-215.
10. Bramham C.R. Control of synaptic consolidation in the dentate gyrus: mechanisms, functions, and therapeutic implications. Prog. Brain Res. 2007, 163:453-471.
11. Bramham C.R., Alme M.N., Bittins M., Kuipers S.D., Nair R.R., Pai B., et al. The Arc of synaptic memory. Exp. Brain Res. 2010, 200:125-140.
12. Choudary P.V., Molnar M., Evans S.J., Tomita H., Li J.Z., Vawter M.P., et al. Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:15653-15658.
13. Christensen R., Kristensen P.K., Bartels E.M., Bliddal H., Astrup A. Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet 2007, 370:1706-1713.
14. Costa-Mattioli M., Sossin W.S., Klann E., Sonenberg N. Translational control of long-lasting synaptic plasticity and memory. Neuron 2009, 61:10-26.
15. de Jong E.K., Vinet J., Stanulovic V.S., Meijer M., Wesseling E., Sjollema K., et al. Expression, transport, and axonal sorting of neuronal CCL21 in large dense-core vesicles. FASEB J. 2008, 22:4136-4145.
16. Dinan T.G. Inflammatory markers in depression. Curr. Opin. Psychiatry 2009, 22:32-36.
17. Froger N., Palazzo E., Boni C., Hanoun N., Saurini F., Joubert C., et al. Neurochemical and behavioral alterations in glucocorticoid receptor-impaired transgenic mice after chronic mild stress. J. Neurosci. 2004, 24:2787-2796.
18. Garcia-Garcia A.L., Elizalde N., Matrov D., Harro J., Wojcik S.M., Venzala E., et al. Increased vulnerability to depressive-like behavior of mice with decreased expression of VGLUT1. Biol. Psychiatry 2009, 66:275-282.
19. Hajszan T., Dow A., Warner-Schmidt J.L., Szigeti-Buck K., Sallam N.L., Parducz A., et al. Remodeling of hippocampal spine synapses in the rat learned helplessness model of depression. Biol. Psychiatry 2009, 65:392-400.
20. Hovatta I., Tennant R.S., Helton R., Marr R.A., Singer O., Redwine J.M., et al. Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice. Nature 2005, 438:662-666.
21. Huang D.W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources. Nat. Protoc. 2009, 4:44-57.
22. Hunsberger J.G., Newton S.S., Bennett A.H., Duman C.H., Russell D.S., Salton S.R., et al. Antidepressant actions of the exercise-regulated gene VGF. Nat. Med. 2007, 13:1476-1482.
23. Hunsberger J.G., Austin D.R., Chen G., Manji H.K. Cellular mechanisms underlying affective resiliency: the role of glucocorticoid receptor- and mitochondrially-mediated plasticity. Brain Res. 2009, 1293:76-84.
24. Jolliffe I.T. Principal Component Analysis 1986, Springer-Verlag, New York.
25. Kajiyama Y., Iijima Y., Chiba S., Furuta M., Ninomiya M., Izumi A., et al. Prednisolone causes anxiety- and depression-like behaviors and altered expression of apoptotic genes in mice hippocampus. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34:159-165.
26. Kang H.J., Adams D.H., Simen A., Simen B.B., Rajkowska G., Stockmeier C.A., et al. Gene expression profiling in postmortem prefrontal cortex of major depressive disorder. J. Neurosci. 2007, 27:13329-13340.
27. Kim K.S., Han P.L. Optimization of chronic stress paradigms using anxiety- and depression-like behavioral parameters. J. Neurosci. Res. 2006, 83:497-507.
28. Kim S., Webster M.J. Correlation analysis between genome-wide expression profiles and cytoarchitectural abnormalities in the prefrontal cortex of psychiatric disorders. Mol. Psychiatry 2008.
29. Klempan T.A., Ernst C., Deleva V., Labonte B., Turecki G. Characterization of QKI gene expression, genetics, and epigenetics in suicide victims with major depressive disorder. Biol. Psychiatry 2009, 66:824-831.
30. Klempan T.A., Sequeira A., Canetti L., Lalovic A., Ernst C., ffrench-Mullen J., et al. Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression. Mol. Psychiatry 2009, 14:175-189.
31. Kohda K., Jinde S., Iwamoto K., Bundo M., Kato N., Kato T. Maternal separation stress drastically decreases expression of transthyretin in the brains of adult rat offspring. Int. J. Neuropsychopharmacol. 2006, 9:201-208.
32. Kozlovsky N., Matar M.A., Kaplan Z., Kotler M., Zohar J., Cohen H. The immediate early gene Arc is associated with behavioral resilience to stress exposure in an animal model of posttraumatic stress disorder. Eur. Neuropsychopharmacol. 2008, 18:107-116.
33. Lalovic A., Klempan T., Sequeira A., Luheshi G., Turecki G. Altered expression of lipid metabolism and immune response genes in the frontal cortex of suicide completers. J. Affect. Disord. 2010, 120:24-31.
34. Lanfumey L., Mannoury La C.C., Froger N., Hamon M. 5-HT-HPA interactions in two models of transgenic mice relevant to major depression. Neurochem. Res. 2000, 25:1199-1206.
35. Li N., Lee B., Liu R.J., Banasr M., Dwyer J.M., Iwata M., et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 2010, 329:959-964.
36. Liebl C., Panhuysen M., Putz B., Trumbach D., Wurst W., Deussing J.M., et al. Gene expression profiling following maternal deprivation: involvement of the brain Renin-Angiotensin system. Front Mol. Neurosci. 2009, 2:1.
37. Martin M., Ledent C., Parmentier M., Maldonado R., Valverde O. Involvement of CB1 cannabinoid receptors in emotional behaviour. Psychopharmacology (Berl.) 2002, 159:379-387.
38. Orsetti M., Di B.F., Canonico P.L., Genazzani A.A., Ghi P. Gene regulation in the frontal cortex of rats exposed to the chronic mild stress paradigm, an animal model of human depression. Eur. J. Neurosci. 2008, 27:2156-2164.
39. Orsetti M., Di B.F., Rinaldi M., Dallorto D., Ghi P. Some molecular effectors of antidepressant action of quetiapine revealed by DNA microarray in the frontal cortex of anhedonic rats. Pharmacogenet. Genomics 2009, 19:600-612.
40. Pei Q., Zetterstrom T.S., Sprakes M., Tordera R., Sharp T. Antidepressant drug treatment induces Arc gene expression in the rat brain. Neuroscience 2003, 121:975-982.
41. Poirier R., Cheval H., Mailhes C., Charnay P., Davis S., Laroche S. Paradoxical role of an Egr transcription factor family member, Egr2/Krox20, in learning and memory. Front Behav. Neurosci. 2007, 1:6.
42. Sato H., Horikawa Y., Iizuka K., Sakurai N., Tanaka T., Shihara N., et al. Large-scale analysis of glucocorticoid target genes in rat hypothalamus. J. Neurochem. 2008, 106:805-814.
43. Schmidt T.S., Alp N.J. Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease. Clin. Sci. (Lond.) 2007, 113:47-63.
44. Sequeira A., Klempan T., Canetti L., ffrench-Mullen J., Benkelfat C., Rouleau G.A., et al. Patterns of gene expression in the limbic system of suicides with and without major depression. Mol. Psychiatry 2007, 12:640-655.
45. Sequeira A., Mamdani F., Ernst C., Vawter M.P., Bunney W.E., Lebel V., et al. Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PLoS ONE 2009, 4:e6585.
46. Sibille E., Wang Y., Joeyen-Waldorf J., Gaiteri C., Surget A., Oh S., et al. A molecular signature of depression in the amygdala. Am. J. Psychiatry 2009, 166:1011-1024.
47. Sillaber I., Panhuysen M., Henniger M.S., Ohl F., Kuhne C., Putz B., et al. Profiling of behavioral changes and hippocampal gene expression in mice chronically treated with the SSRI paroxetine. Psychopharmacology (Berl.) 2008, 200:557-572.
48. Slattery D.A., Morrow J.A., Hudson A.L., Hill D.R., Nutt D.J., Henry B. Comparison of alterations in c-fos and Egr-1 (zif268) expression throughout the rat brain following acute administration of different classes of antidepressant compounds. Neuropsychopharmacology 2005, 30:1278-1287.
49. Slipczuk L., Bekinschtein P., Katche C., Cammarota M., Izquierdo I., Medina J.H. BDNF activates mTOR to regulate GluR1 expression required for memory formation. PLoS ONE 2009, 4:e6007.
50. Smyth G.K. Limma: linear models for microarray data. Bioinformatics and Computational Biology Solutions using R and Bioconductor 2005, 397-420. Springer-Verlag, New York. R. Gentleman, V. Carey, R. Irizarry, V. Huber (Eds.).
51. Sokolov B.P. Oligodendroglial abnormalities in schizophrenia, mood disorders and substance abuse. Comorbidity, shared traits, or molecular phenocopies?. Int. J. Neuropsychopharmacol. 2007, 10:547-555.
52. Surget A., Wang Y., Leman S., Ibarguen-Vargas Y., Edgar N., Griebel G., et al. Corticolimbic transcriptome changes are state-dependent and region-specific in a rodent model of depression and of antidepressant reversal. Neuropsychopharmacology 2009, 34:1363-1380.
53. Tochigi M., Iwamoto K., Bundo M., Sasaki T., Kato N., Kato T. Gene expression profiling of major depression and suicide in the prefrontal cortex of postmortem brains. Neurosci. Res. 2008, 60:184-191.
54. Tukey J.W. Exploratory Data Analysis 1977, Addison-Wesley, Reading Massachusetts.
55. Uriguen L., Arteta D., ez-Alarcia R., Ferrer-Alcon M., Diaz A., Pazos A., et al. Gene expression patterns in brain cortex of three different animal models of depression. Genes Brain Behav. 2008, 7:649-658.
56. van Heerden J.H., Conesa A., Stein D.J., Montaner D., Russell V., Illing N. Parallel changes in gene expression in peripheral blood mononuclear cells and the brain after maternal separation in the mouse. BMC Res. Notes 2009, 2:195.